A Multicenter, Randomized Trial to Compare 2 Link Nobori and 3 Link Xience Stents in Bifurcation Stenting
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BEGIN
- 06 Apr 2017 The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years. Lastly Verified in April 2015
- 01 Jun 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
- 16 Apr 2013 New source identified and integrated (University Hospital Medical Information Network - Japan: UMIN000007764).